News
New Constellation Board of Directors Named
Exelon Corp. (Nasdaq: EXC) today announced Constellation’s Board of Directors following the company’s separation from Exelon. The transaction, which has received all regulatory approvals and is
Form 8.3 - The Vanguard Group, Inc.: NortonLife Lock Inc.
Lindsay Corporation Announces Quarterly Dividend
Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, announced today that its Board of Directors has declared a
DGAP-Adhoc: PAION ASSIGNS CHINESE REMIMAZOLAM PATENTS AND SELLS RELATED FUTURE ROYALTIES FOR EUR 20.5 MILLION TO HUMANWELL HEALTHCARE GROUP
DGAP-Adhoc: Biotest AG: Grifols, S.A. will hold more than 95,5498 % of the voting rights upon settlement of the takeover offer
DGAP-News: Steinhoff International Holdings N.V. : SATISFACTION OF SUSPENSIVE CONDITIONS UNDER SIHPL NQC SETTLEMENTS
Nordic Enterprises Prove Digital Leadership With Transformations to Compete in Post-Pandemic World
The COVID-19 pandemic has accelerated adoption of digital solutions in the Nordic region, which already led Europe in this area before the crisis, according to a new research report published today
argenx Highlights Strategic Priorities for 2022
Regulatory News:
argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced its strategic
NOXXON Provides Progress Update on the Expansion Arms of the Phase 1/2 GLORIA Trial With NOX-A12 in Brain Cancer Patients
Regulatory News:
NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME)
Exscientia and Sanofi Establish Strategic Research Collaboration to Develop AI-driven Pipeline of Precision-Engineered Medicines
Sanofi and Exscientia announced today a groundbreaking research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology, leveraging
QIAGEN Strengthens Growing Portfolio of Applications for Its Digital PCR Platform QIAcuity With New Collaborations
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced new additions to the growing number of applications for QIAcuity, its ultrasensitive digital PCR (dPCR) platform that has set
DGAP-News: Symrise accelerates international expansion in Pet Nutrition through acquisition of Schaffelaarbos
DGAP-News: MorphoSys Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
DGAP-Adhoc: MorphoSys AG Reports Preliminary 2021 Monjuvi U.S. Sales and Provides 2022 Financial Guidance
KKR Real Estate Finance Trust Inc. Announces Pricing of Public Offering of Additional Shares of 6.50% Series A Cumulative Redeemable Preferred Stock
KKR Real Estate Finance Trust Inc. (“KREF”) (NYSE: KREF) today announced the pricing of a public offering of 4,400,000 additional shares of its 6.50% Series A Cumulative Redeemable Preferred Stock
Columbia Care Announces Commencement of Noteholder Consent Solicitation to Increase Debt Capacity
Columbia Care Inc. (NEO: CCHW) (CSE:CCHW) (OTCQX:CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”), one of the largest and most experienced cultivators, manufacturers and providers of cannabis
Atmos Energy Corporation to Host Fiscal 2022 First Quarter Earnings Conference Call on February 9, 2022
Atmos Energy Corporation (NYSE: ATO) will host a conference call on Wednesday, February 9, at 9 a.m. Eastern to review the company’s Fiscal 2022 first quarter financial results. Atmos Energy will
ADTRAN Stockholders Overwhelmingly Approve Business Combination with ADVA Optical Networking SE
ADTRAN, Inc., (NASDAQ: ADTN) today announced that its stockholders have approved the business combination with ADVA Optical Networking SE by an overwhelming majority. In a Special Meeting of
Xencor to Present at the H.C. Wainwright Bioconnect Virtual Conference
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced
Kopin to Participate in Upcoming Virtual Investor Event
Kopin Corporation (NASDAQ: KOPN), a leading provider of innovative wearable computing technologies and solutions, announced today that Mr. Richard Sneider, Chief Financial Officer, will present at
QIAGEN Expands QuantiFERON Portfolio in the Fight Against TB
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced important expansion initiatives for its QuantiFERON franchise, building on its status as the gold standard for detection of
Simulations Plus Reports First Quarter Fiscal 2022 Financial Results
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today reported financial results for its first
Franklin Covey Reports Strong Start to Fiscal 2022
Franklin Covey Co. (NYSE: FC), a global performance improvement company that creates, and on a subscription basis, distributes world-class content, training, processes, and tools that organizations
Royal Gold Presenting at the 25th Annual CIBC Western Institutional Investor Conference (Virtual)
Royal Gold, Inc. (NASDAQ: RGLD) (together with its subsidiaries, “Royal Gold” or the “Company,” “we” or “our”) announced today that management will present in the 25th Annual CIBC Western